Evidence map›Paper›PMID 31822785›Full record

ArticleJournal of human genetics2020

Reply to: "Development of an MSI-positive colon tumor with aberrant DNA methylation in a PPAP patient".

Pilar Mur, Claire Palles, Ian Tomlinson, Laura Valle

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Unraveling the impact of a germline heterozygousFrontiers in molecular biosciences · 2023
    Article
  3. Role of POLE and POLD1 in familial cancer.Genetics in medicine : official journal of the American College of Medical Genetics · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Pilar MurHereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.
Claire PallesGastrointestinal Cancer Genetics Laboratory, Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, UK.
Ian TomlinsonEdinburgh Cancer Research Centre, IGMM, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0003-3037-1470
Laura ValleHereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain. lvalle@idibell.cat.ORCID http://orcid.org/0000-0003-0371-0844
Institut d'Investigació Biomédica de Bellvitge · ESEdinburgh Cancer Research · GBUniversity of Birmingham · GB

Funding

European Cooperation in Science and Technology (COST) CA17118Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) CIBERONC CB16/12/00234Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) Sara Borrell Postdoctoral contract
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DNA MethylationColonic NeoplasmsHumansMicrosatellite InstabilityPropylaminesN-(3-phenyl-n-propyl)-1-phenyl-2-aminopropanePropylamines

Identifiers

PMID31822785
OpenAlexW2994791489

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.